通过肝移植和eculizumab治疗的Budd-Chiari综合征的CD55缺乏症

Sinja Ohlsson1, Elke Lainka1, Christoph Hünseler2

  • 1Department of Pediatrics II, Pediatric Gastroenterology, Hepatology and Liver Transplantation, University Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Pediatrics
|November 29, 2023
PubMed
概括

CD55缺乏症是一种罕见的遗传疾病,在一个年轻的患者身上引起了严重的蛋白质损失肠道病变和Budd-Chiari综合征. 治疗eculizumab导致持续的临床缓解,强调了CD55检测的重要性.